4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-24-092170
CEO and President sold 32,441 shares at an average $1.31 ($42,646)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sath CEO and President | 2024-08-02 | Sale | −14,800 | $1.32 | $19,536 | 1,161,207 | D |
| Shukla Sath CEO and President | 2024-08-05 | Sale | −17,641 | $1.31 | $23,110 | 1,143,566 | D |
| Open-market sales · 32,441 sh · avg $1.31 · $42,646 | |||||||
Loading xslF345X05/ownership.xml…